REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal diseases. "2026 is set to be a transformative year ...

Global Professionals Achieve Verified Recognition Through Web Developer Certification and Credly Digital Credentials

Professionals worldwide gain standardized recognition for web development skills through assessment-based certification ...

Milwaukee Film rebrands with new logo, website redesign

The new logo and website redesign come nearly a year after Susan Kerns took over the struggling nonprofit as executive ...

Trump’s controversial ballroom could solve a decades-long problem — and is taking the first formal steps for construction

President Donald Trump’s sprawling new East Wing ballroom project has attracted widespread controversy — but promises to ...
PCMag

This ThinkPad's Stretchy Display Dazzled Me: It Makes a 180 Over the Top of the Lid

Lenovo's outrageous ThinkPad Rollable XD prototype laptop one-ups the company's already impressive 2025 rolling-screen ...